Leonteq Securities’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$48.8K Buy
1,093
+1,020
+1,397% +$58K ﹤0.01% 781
2026
Q2
$5.79K Hold
73
– – ﹤0.01% 1077
2026
Q1
$5.48K Buy
73
+10
+16% +$789 ﹤0.01% 1115
2025
Q4
$4.98K Hold
63
– – ﹤0.01% 1252
2025
Q3
$4.12K Hold
63
– – ﹤0.01% 1183
2025
Q2
$2.49K Hold
63
– – ﹤0.01% 1165
2025
Q1
$1.9K Hold
63
– – ﹤0.01% 1150
2024
Q4
$2.2K Hold
63
– – ﹤0.01% 1153
2024
Q3
$2.52K Buy
+63
New +$2.93K ﹤0.01% 1089
2024
Q2
– Sell
-212
Closed -$9.19K – 1250
2024
Q1
$9.19K Buy
+212
New +$10.1K ﹤0.01% 1027
2023
Q4
– Sell
-130
Closed -$5.9K – 1239
2023
Q3
$5.9K Buy
+130
New +$5.36K ﹤0.01% 1053
2023
Q2
– Sell
-55
Closed -$1.97K – 1268
2023
Q1
$1.97K Sell
55
-468
-89% -$17.6K ﹤0.01% 1151
2022
Q4
$19.8K Buy
523
+209
+67% +$8.79K ﹤0.01% 968
2022
Q3
$13.9K Sell
314
-1,640
-84% -$69.1K ﹤0.01% 1009
2022
Q2
$72.3K Sell
1,954
-273
-12% -$10.3K ﹤0.01% 752
2022
Q1
$82.5K Sell
2,227
-4,009
-64% -$131K ﹤0.01% 773
2021
Q4
$190K Buy
6,236
+757
+14% +$23.8K 0.01% 635
2021
Q3
$184K Buy
5,479
+2,282
+71% +$86K 0.01% 607
2021
Q2
$128K Buy
3,197
+1,672
+110% +$65.5K 0.01% 669
2021
Q1
$68.6K Sell
1,525
-1,631
-52% -$91K ﹤0.01% 750
2020
Q4
$178K Buy
+3,156
New +$157K 0.01% 580

Other funds holding IONS

Leonteq Securities's IONS Position: Q3 2026 in Review

Leonteq Securities increased its Ionis Pharmaceuticals (IONS) stake by 1,397% in Q3 2026, buying an estimated $58K and bringing the position to 1,093 shares worth $48.8K. The position accounts for ﹤0.01% of the portfolio, ranked #781.

Leonteq Securities first reported a position in IONS in Q4 2020 and has held it in 21 quarters since. The position peaked at $190K in Q4 2021. 356 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • Leonteq Securities held 1,093 shares of Ionis Pharmaceuticals worth $48.8K as of Q3 2026.
  • Leonteq Securities bought 1,020 Ionis Pharmaceuticals shares in Q3 2026, an estimated $58K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Leonteq Securities's portfolio in Q3 2026, its #781 holding.
  • Leonteq Securities first reported a position in Ionis Pharmaceuticals in Q4 2020 and has held it in 21 quarters since.
  • Leonteq Securities's Ionis Pharmaceuticals position peaked at $190K in Q4 2021.
  • 356 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.